News

A world-first clinical trial has been launched at Sydney Children’s Hospital, Randwick for children with ependymoma – a rare and devastating form of paediatric brain cancer.

Steps are being taken by SCHN to improve equity of access and service management for those living with a rare disease via The Navigator Project.

Over $2 million in funding has been awarded by Luminesce Alliance to support the Providing Enhanced Access to Child Health Services Evaluation (PEACH-E) project.

A SCHN study investigated the outcomes of using parental and staff feedback to develop and evaluate the service of the ‘Difficult to Vaccinate’ clinical pathway.

More than $18.7 million in funding has been allocated to researchers across SCHN through the latest MRFF grant.